Aura Biosciences, Inc.
AURA
$7.64
-$0.01-0.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.23% | -18.69% | -22.17% | -27.94% | -25.65% |
| Total Depreciation and Amortization | -8.04% | -7.95% | -7.69% | -8.60% | -8.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 95.84% | 45.93% | 68.16% | 62.44% | 44.65% |
| Change in Net Operating Assets | -28.35% | 11.74% | 326.00% | 939.22% | 318.52% |
| Cash from Operations | -23.58% | -15.97% | -6.19% | -20.46% | -13.61% |
| Capital Expenditure | 60.28% | 73.22% | 64.33% | 55.15% | 15.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -305.00% | -32.62% | -48.57% | 172.47% | 336.02% |
| Cash from Investing | -307.37% | -32.00% | -48.28% | 169.55% | 327.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 457.49% | 3,643.12% | 3,269.59% | -45.21% | -49.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.67% | -- | -- | -- | -- |
| Cash from Financing | 249.56% | 5,279.62% | 4,737.30% | -20.32% | -24.92% |
| Foreign Exchange rate Adjustments | -3,016.67% | -814.29% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.15% | 289.78% | 396.33% | 173.34% | 537.25% |